COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read moreHistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read moreThe range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly
Read moreGSK and Vir Biotechnology announced that the monoclonal antibody sotrovimab (VIR-7831) has received Emergency Use Authorization (EUA) from the US
Read moreGSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreGSK has made an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support the production of
Read moreNew data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read moreAmgen and Five Prime Therapeutics, a clinical-stage biotech corporation focusing on discovering immuno-oncology and personalized cancer treatments, announced on the
Read moreSanofi is set to acquire Cambridge, UK-headquartered Kymab and thereby add KY1005 to its pipeline, a human monoclonal antibody targeting
Read moreWith the anti-lamin B1 mouse specific antibody and the anti-lamin B1 human specific antibody developed by HistoSure, researchers can distinguish
Read moreThis monoclonal anti-mutated Calreticulin CALR (CAL2) antibody recognises all forms of C-terminus mutated CALR. Calreticulin (CALR) mutations Calreticulin (CALR) mutations
Read more